Combining radioembolization and immune checkpoint inhibitors for the treatment of hepatocellular carcinoma: The quest for synergy

Authors

Christopher D Malone, Washington University School of Medicine in St. Louis
Suryansh Bajaj, University of Arkansas at Little Rock
Aiwu He, MedStar Health
Kabir Mody, Moderna, Inc
Ryan M Hickey, New York University
Ammar Sarwar, Harvard University
Sunil Krishnan, University of Texas Health Science Center at Houston
Tushar C Patel, Mayo Clinic
Beau B Toskich, Mayo Clinic

Journal

Journal of Vascular and Interventional Radiology

Publication Date

3-1-2025

Volume

36

Issue

3

First Page

414

Last Page

424.e2

Document Type

Open Access Publication

DOI

10.1016/j.jvir.2024.11.012

Rights and Permissions

Malone CD, Bajaj S, He A, Mody K, Hickey RM, Sarwar A, Krishnan S, Patel TC, Toskich BB. Combining Radioembolization and Immune Checkpoint Inhibitors for the Treatment of Hepatocellular Carcinoma: The Quest for Synergy. J Vasc Interv Radiol. 2025 Mar;36(3):414-424.e2. doi: 10.1016/j.jvir.2024.11.012. © SIR, 2024. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Malone, Christopher D; Bajaj, Suryansh; He, Aiwu; Mody, Kabir; Hickey, Ryan M; Sarwar, Ammar; Krishnan, Sunil; Patel, Tushar C; and Toskich, Beau B, "Combining radioembolization and immune checkpoint inhibitors for the treatment of hepatocellular carcinoma: The quest for synergy." Journal of Vascular and Interventional Radiology. 36, 3. 414 - 424.e2. (2025).
https://digitalcommons.wustl.edu/oa_4/5965

Department

ICTS (Institute of Clinical and Translational Sciences)